![]() ![]() ![]() The pediatric formulation will be given in smaller doses - 10 mcg (micrograms) instead of the 30 mcg used for people 12 years of age and older.Īccording to a spokesperson for Pfizer Canada, the vials for the pediatric version will each contain 10 doses and have a "unique label," and the cap will be a different colour - so health-care workers will be able to tell the difference between the adult and child versions. Those 12 and older get the already approved adult formulation. The pediatric version of the vaccine is for kids age five to 11. Pfizer-BioNTech is the first company to seek Health Canada's approval for a pediatric COVID-19 vaccine (although other companies, such as Moderna, are working on children's formulations). Here's what we've been able to find out: What do we know about Pfizer's pediatric COVID-19 vaccine? Since Health Canada announced last week that Pfizer-BioNTech is seeking authorization for its COVID-19 vaccine for younger children, many people have been asking questions. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |